Rx Reimportation Ban In Australia Free Trade Deal Questioned By Sen. Grassley
This article was originally published in The Pink Sheet Daily
Executive Summary
The reimportation issue is still being debated in Congress, Grassley notes. The trade agreement calls for changes to Australia's Pharmaceutical Benefits Scheme, including independent review of product inclusion.